[{"orgOrder":0,"company":"Prisma Health-Midlands","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"","productType":"Plant Extract\/Herbal","year":"2021","type":"Inapplicable","leadProduct":"Astaxanthin","moa":"||NF-kappa-B inhibitor alpha","graph1":"Musculoskeletal","graph2":"Phase II\/ Phase III","graph3":"Prisma Health-Midlands","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Oral","sponsorNew":"Prisma Health-Midlands \/ Inapplicable","highestDevelopmentStatusID":"9","companyTruncated":"Prisma Health-Midlands \/ Inapplicable"},{"orgOrder":0,"company":"LycoRed Ltd.","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Astaxanthin","moa":"||NF-kappa-B inhibitor alpha","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"LycoRed Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Oral Capsule","sponsorNew":"LycoRed Ltd. \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"LycoRed Ltd. \/ Nutrasource"},{"orgOrder":0,"company":"Appalachian State University","sponsor":"LycoRed Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Astaxanthin","moa":"||NF-kappa-B inhibitor alpha","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Appalachian State University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Oral Capsule","sponsorNew":"Appalachian State University \/ LycoRed Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"Appalachian State University \/ LycoRed Ltd."},{"orgOrder":0,"company":"Duta Wacana Christian University","sponsor":"PT SOHO Global Health Tbk","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"","productType":"Plant Extract\/Herbal","year":"2020","type":"Inapplicable","leadProduct":"Astaxanthin","moa":"||NF-kappa-B inhibitor alpha","graph1":"Neurology","graph2":"Phase II\/ Phase III","graph3":"Duta Wacana Christian University","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Duta Wacana Christian University \/ PT SOHO Global Health Tbk","highestDevelopmentStatusID":"9","companyTruncated":"Duta Wacana Christian University \/ PT SOHO Global Health Tbk"},{"orgOrder":0,"company":"BioAdaptives","sponsor":"LY Research Corporation","pharmaFlowCategory":"D","therapeuticArea":"Ophthalmology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2023","type":"Licensing Agreement","leadProduct":"Lutein","moa":"||Undisclosed","graph1":"Ophthalmology","graph2":"Preclinical","graph3":"BioAdaptives","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"BioAdaptives \/ LY Research Corporation","highestDevelopmentStatusID":"4","companyTruncated":"BioAdaptives \/ LY Research Corporation"},{"orgOrder":0,"company":"Integrative Skin Science and Research","sponsor":"AstaReal","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Plant Extract\/Herbal","year":"2023","type":"Inapplicable","leadProduct":"Astaxanthin","moa":"||NF-kappa-B inhibitor alpha","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Integrative Skin Science and Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Integrative Skin Science and Research \/ AstaReal","highestDevelopmentStatusID":"1","companyTruncated":"Integrative Skin Science and Research \/ AstaReal"},{"orgOrder":0,"company":"3 Waves Wellness","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Algae Extract","moa":"||Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Undisclosed","graph3":"3 Waves Wellness","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"3 Waves Wellness \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"3 Waves Wellness \/ Inapplicable"}]

Find Clinical Drug Pipeline Developments & Deals for Astaxanthin

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Integrative Skin Science and Research

                          Country arrow
                          EPSC
                          Not Confirmed

                          Integrative Skin Science and Research

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          May 31, 2023

                          Lead Product(s) : Astaxanthin,Inapplicable

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : AstaReal

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Details : The agreement aims to market a patented product for Eye Health due to Myopia and Presbyopia. This Patent is a liposome and sustained release polymeric micelles preparation that improves the solubility of lutein.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Undisclosed

                          March 30, 2023

                          Lead Product(s) : Lutein,Astaxanthin

                          Therapeutic Area : Ophthalmology

                          Highest Development Status : Preclinical

                          Sponsor : LY Research Corporation

                          Deal Size : Undisclosed

                          Deal Type : Licensing Agreement

                          blank

                          03

                          3 Waves Wellness

                          Country arrow
                          EPSC
                          Not Confirmed

                          3 Waves Wellness

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          August 19, 2022

                          Lead Product(s) : Chaga Mushroom,Algae Extract,Black Cumin Seed,Astaxanthin,Omega 3

                          Therapeutic Area : Psychiatry/Psychology

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Appalachian State University

                          Country arrow
                          EPSC
                          Not Confirmed

                          Appalachian State University

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          June 08, 2022

                          Lead Product(s) : Astaxanthin,Inapplicable

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Undisclosed

                          Sponsor : LycoRed Ltd.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          LycoRed Ltd.

                          Country arrow
                          EPSC
                          Not Confirmed

                          LycoRed Ltd.

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          May 17, 2022

                          Lead Product(s) : Astaxanthin,Inapplicable

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Nutrasource

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          Prisma Health-Midlands

                          Country arrow
                          EPSC
                          Not Confirmed

                          Prisma Health-Midlands

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          December 01, 2021

                          Lead Product(s) : Astaxanthin,Inapplicable

                          Therapeutic Area : Musculoskeletal

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          Duta Wacana Christian University

                          Country arrow
                          EPSC
                          Not Confirmed

                          Duta Wacana Christian University

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          December 30, 2020

                          Lead Product(s) : Astaxanthin,Inapplicable

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase II/ Phase III

                          Sponsor : PT SOHO Global Health Tbk

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          NextFerm Technologies LTD

                          Country arrow
                          EPSC
                          Not Confirmed

                          NextFerm Technologies LTD

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          January 16, 2019

                          Lead Product(s) : Astaxanthin,Inapplicable

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          March 09, 2018

                          Lead Product(s) : Astaxanthin,Lycopene,Vitamin E

                          Therapeutic Area : Dermatology

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          10

                          Algatechnologies Ltd.

                          Country arrow
                          EPSC
                          Not Confirmed

                          Algatechnologies Ltd.

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          February 23, 2018

                          Lead Product(s) : Astaxanthin,Inapplicable

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase I

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank